{"id":26318,"date":"2018-08-02T01:00:00","date_gmt":"2018-08-09T03:42:42","guid":{"rendered":"http:\/\/www.05921.net\/index.php\/2018\/08\/09\/%e7%9b%ae%e5%89%8d%e7%bc%ac%e6%b2%99%e5%9d%a6cep%e6%8c%81%e6%9c%89%e6%83%85%e5%86%b5\/"},"modified":"2018-08-09T11:42:44","modified_gmt":"2018-08-09T03:42:44","slug":"%e7%9b%ae%e5%89%8d%e7%bc%ac%e6%b2%99%e5%9d%a6cep%e6%8c%81%e6%9c%89%e6%83%85%e5%86%b5","status":"publish","type":"post","link":"https:\/\/www.05921.net\/index.php\/26318\/","title":{"rendered":"\u76ee\u524d\u7f2c\u6c99\u5766CEP\u6301\u6709\u60c5\u51b5"},"content":{"rendered":"
\n

\u7ffb\u8bd1\uff1aJULIA \u6765\u6e90\uff1a<\/span>Julia\u6cd5\u89c4\u7ffb\u8bd1<\/span> <\/span><\/p>\n


<\/span><\/p>\n

\u76ee\u524d\u7f2c\u6c99\u5766CEP\u6301\u6709\u60c5\u51b5<\/span><\/strong><\/p>\n


<\/span><\/strong><\/p>\n

\u5171\u670928\u4efdCEP\uff0c\u5206\u522b\u753122\u5bb6\u516c\u53f8\u6301\u6709\uff0c28\u4efd\u4e2d\u67092\u53ea\u88ab\u6401\u7f6e\uff0c3\u4efd\u88ab\u6301\u6709\u4eba\u64a4\u56de\uff0c\u5176\u4e2d\u534e\u6d77CEP\u88ab\u6401\u7f6e\u65e5\u671f\u4e3a2018\u5e747\u67089\u65e5\u3002<\/span><\/p>\n


<\/span><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

Substance<\/span><\/strong><\/p>\n<\/td>\n

\n

Certificate Holder<\/span><\/strong><\/p>\n<\/td>\n

\n

Certificate Number<\/span><\/strong><\/p>\n<\/td>\n

\n

Issue Date<\/span><\/strong><\/p>\n<\/td>\n

\n

Status<\/span><\/strong><\/p>\n<\/td>\n

\n

End date<\/span><\/strong><\/p>\n<\/td>\n<\/tr>\n

\n

Valsartan Process II<\/span><\/p>\n<\/td>\n

\n

ALEMBIC PHARMACEUTICALS  LIMITED IN 390 003  Vadodara<\/span><\/p>\n<\/td>\n

\n

  R0-CEP  2014-075-Rev 00<\/span><\/p>\n<\/td>\n

\n

13\/04\/2016<\/span><\/p>\n<\/td>\n

\n

VALID<\/span><\/p>\n<\/td>\n


<\/td>\n<\/tr>\n
\n

Valsartan<\/span><\/p>\n<\/td>\n

\n

ALEMBIC  PHARMACEUTICALS LIMITED IN 390 003  Vadodara<\/span><\/p>\n<\/td>\n

\n

  R1-CEP  2010-065-Rev 03<\/span><\/p>\n<\/td>\n

\n

27\/07\/2018<\/span><\/p>\n<\/td>\n

\n

VALID<\/span><\/p>\n<\/td>\n


<\/td>\n<\/tr>\n
\n

Valsartan Process II<\/span><\/p>\n<\/td>\n

\n

AUROBINDO PHARMA  LIMITED IN 500 038  Hyderabad<\/span><\/p>\n<\/td>\n

\n

  R1-CEP  2011-174-Rev 00<\/span><\/p>\n<\/td>\n

\n

03\/08\/2017<\/span><\/p>\n<\/td>\n

\n

VALID<\/span><\/p>\n<\/td>\n


<\/td>\n<\/tr>\n
\n

Valsartan Process II,  o-Xylene route<\/span><\/p>\n<\/td>\n

\n

AUROBINDO PHARMA  LIMITED IN 500 038 Hyderabad<\/span><\/p>\n<\/td>\n

\n

  R0-CEP  2016-101-Rev 00<\/span><\/p>\n<\/td>\n

\n

19\/08\/2016<\/span><\/p>\n<\/td>\n

\n

VALID<\/span><\/p>\n<\/td>\n


<\/td>\n<\/tr>\n
\n

Valsartan<\/span><\/p>\n<\/td>\n

\n

DIVI’S LABORATORIES  LIMITED IN 500 032  Hyderabad<\/span><\/p>\n<\/td>\n

\n

  R0-CEP  2012-338-Rev 02<\/span><\/p>\n<\/td>\n

\n

12\/08\/2016<\/span><\/p>\n<\/td>\n

\n

VALID<\/span><\/p>\n<\/td>\n


<\/td>\n<\/tr>\n
\n

Valsartan<\/span><\/p>\n<\/td>\n

\n

DR. REDDY’S  LABORATORIES LIMITED IN 500 034  Hyderabad<\/span><\/p>\n<\/td>\n

\n

  R1-CEP  2009-405-Rev 00<\/span><\/p>\n<\/td>\n

\n

04\/08\/2016<\/span><\/p>\n<\/td>\n

\n

VALID<\/span><\/p>\n<\/td>\n


<\/td>\n<\/tr>\n
\n

Valsartan<\/span><\/p>\n<\/td>\n

\n

GRANULES INDIA LIMITED  IN 500 081 Hyderabad<\/span><\/p>\n<\/td>\n

\n

  R0-CEP  2013-012-Rev 00<\/span><\/p>\n<\/td>\n

\n

05\/03\/2015<\/span><\/p>\n<\/td>\n

\n

WITHDRAWN BY HOLDER<\/span><\/p>\n<\/td>\n

\n

03\/01\/2018<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

Valsartan<\/span><\/p>\n<\/td>\n

\n

HARMAN FINOCHEM  LIMITED IN 400 098 Mumbai<\/span><\/p>\n<\/td>\n

\n

  R0-CEP  2016-026-Rev 00<\/span><\/p>\n<\/td>\n

\n

10\/11\/2017<\/span><\/p>\n<\/td>\n

\n

VALID<\/span><\/p>\n<\/td>\n


<\/td>\n<\/tr>\n
\n

Valsartan Process III<\/span><\/p>\n<\/td>\n

\n

HETERO LABS LIMITED IN  500 018 Hyderabad<\/span><\/p>\n<\/td>\n

\n

  R0-CEP  2016-069-Rev 01<\/span><\/p>\n<\/td>\n

\n

04\/05\/2018<\/span><\/p>\n<\/td>\n

\n

VALID<\/span><\/p>\n<\/td>\n


<\/td>\n<\/tr>\n
\n

Valsartan Process-II<\/span><\/p>\n<\/td>\n

\n

HETERO LABS LIMITED IN  500 018 Hyderabad<\/span><\/p>\n<\/td>\n

\n

  R0-CEP  2012-296-Rev 02<\/span><\/p>\n<\/td>\n

\n

10\/08\/2017<\/span><\/p>\n<\/td>\n

\n

WITHDRAWN BY HOLDER<\/span><\/p>\n<\/td>\n

\n

25\/05\/2018<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

Valsartan<\/span><\/p>\n<\/td>\n

\n

HETERO LABS LIMITED IN  500 018 Hyderabad<\/span><\/p>\n<\/td>\n

\n

  R0-CEP  2011-246-Rev 01<\/span><\/p>\n<\/td>\n

\n

29\/09\/2015<\/span><\/p>\n<\/td>\n

\n

WITHDRAWN BY HOLDER<\/span><\/p>\n<\/td>\n

\n

08\/09\/2017<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

Valsartan<\/span><\/p>\n<\/td>\n

\n

IPCA Laboratories  Limited IN 400 067 Mumbai<\/span><\/p>\n<\/td>\n

\n

  R1-CEP  2010-100-Rev 01<\/span><\/p>\n<\/td>\n

\n

18\/05\/2018<\/span><\/p>\n<\/td>\n

\n

VALID<\/span><\/p>\n<\/td>\n


<\/td>\n<\/tr>\n
\n

Valsartan<\/span><\/p>\n<\/td>\n

\n

JUBILANT GENERICS  LIMITED IN 571 302  Nanjangud<\/span><\/p>\n<\/td>\n

\n

  R1-CEP  2011-110-Rev 01<\/span><\/p>\n<\/td>\n

\n

27\/06\/2018<\/span><\/p>\n<\/td>\n

\n

VALID<\/span><\/p>\n<\/td>\n


<\/td>\n<\/tr>\n
\n

Valsartan<\/span><\/p>\n<\/td>\n

\n

KRKA d.d. SI 8501 Novo  Mesto<\/span><\/p>\n<\/td>\n

\n

  R1-CEP  2011-148-Rev 00<\/span><\/p>\n<\/td>\n

\n

08\/03\/2018<\/span><\/p>\n<\/td>\n

\n

VALID<\/span><\/p>\n<\/td>\n


<\/td>\n<\/tr>\n
\n

Valsartan<\/span><\/p>\n<\/td>\n

\n

LUPIN LIMITED IN 400  055 Mumbai<\/span><\/p>\n<\/td>\n

\n

  R0-CEP  2012-274-Rev 02<\/span><\/p>\n<\/td>\n

\n

23\/01\/2017<\/span><\/p>\n<\/td>\n

\n

VALID<\/span><\/p>\n<\/td>\n


<\/td>\n<\/tr>\n
\n

Valsartan<\/span><\/p>\n<\/td>\n

\n

MACLEODS  PHARMACEUTICALS LIMITED IN 400 059  Mumbai<\/span><\/p>\n<\/td>\n

\n

  R1-CEP  2011-180-Rev 01<\/span><\/p>\n<\/td>\n

\n

11\/06\/2018<\/span><\/p>\n<\/td>\n

\n

VALID<\/span><\/p>\n<\/td>\n


<\/td>\n<\/tr>\n
\n

Valsartan<\/span><\/p>\n<\/td>\n

\n

MYLAN LABORATORIES  LIMITED IN 500 096  Hyderabad<\/span><\/p>\n<\/td>\n

\n

  R1-CEP  2009-396-Rev 02<\/span><\/p>\n<\/td>\n

\n

11\/01\/2018<\/span><\/p>\n<\/td>\n

\n

VALID<\/span><\/p>\n<\/td>\n


<\/td>\n<\/tr>\n
\n

Valsartan<\/span><\/p>\n<\/td>\n

\n

NOVARTIS PHARMA AG CH  4002 Basel<\/span><\/p>\n<\/td>\n

\n

  R0-CEP  2016-290-Rev 00<\/span><\/p>\n<\/td>\n

\n

06\/12\/2017<\/span><\/p>\n<\/td>\n

\n

VALID<\/span><\/p>\n<\/td>\n


<\/td>\n<\/tr>\n
\n

Valsartan<\/span><\/p>\n<\/td>\n

\n

SECOND PHARMA CO.,  LTD. CN 312 369 Shangyu  City<\/span><\/p>\n<\/td>\n

\n

  R0-CEP  2014-008-Rev 00<\/span><\/p>\n<\/td>\n

\n

03\/02\/2015<\/span><\/p>\n<\/td>\n

\n

VALID<\/span><\/p>\n<\/td>\n


<\/td>\n<\/tr>\n
\n

Valsartan<\/span><\/p>\n<\/td>\n

\n

SIGNA S.A. DE C.V. MX  50071 Toluca<\/span><\/p>\n<\/td>\n

\n

  R0-CEP  2011-231-Rev 00<\/span><\/p>\n<\/td>\n

\n

24\/06\/2014<\/span><\/p>\n<\/td>\n

\n

VALID<\/span><\/p>\n<\/td>\n


<\/td>\n<\/tr>\n
\n

Valsartan Process 3  and Process 5<\/span><\/p>\n<\/td>\n

\n

SUN PHARMACEUTICAL  INDUSTRIES LIMITED IN 400 063 Mumbai<\/span><\/p>\n<\/td>\n

\n

  R0-CEP  2013-335-Rev 03<\/span><\/p>\n<\/td>\n

\n

29\/10\/2015<\/span><\/p>\n<\/td>\n

\n

VALID<\/span><\/p>\n<\/td>\n


<\/td>\n<\/tr>\n
\n

Valsartan<\/span><\/p>\n<\/td>\n

\n

SUN PHARMACEUTICAL  INDUSTRIES LIMITED IN 400  063 Mumbai<\/span><\/p>\n<\/td>\n

\n

  R1-CEP  2010-196-Rev 00<\/span><\/p>\n<\/td>\n

\n

29\/03\/2017<\/span><\/p>\n<\/td>\n

\n

VALID<\/span><\/p>\n<\/td>\n


<\/td>\n<\/tr>\n
\n

Valsartan ID: 7611<\/span><\/p>\n<\/td>\n

\n

Teva Pharmaceutical  Industries Ltd. IL 49131  Petach Tikva<\/span><\/p>\n<\/td>\n

\n

  R0-CEP  2011-121-Rev 00<\/span><\/p>\n<\/td>\n

\n

28\/06\/2013<\/span><\/p>\n<\/td>\n

\n

VALID<\/span><\/p>\n<\/td>\n


<\/td>\n<\/tr>\n
\n

Valsartan<\/span><\/p>\n<\/td>\n

\n

TEVA PHARMACEUTICAL  INDUSTRIES LTD. IL  4951033 Petach Tikva<\/span><\/p>\n<\/td>\n

\n

  R1-CEP  2010-207-Rev 00<\/span><\/p>\n<\/td>\n

\n

29\/09\/2017<\/span><\/p>\n<\/td>\n

\n

VALID<\/span><\/p>\n<\/td>\n


<\/td>\n<\/tr>\n
\n

Valsartan<\/span><\/p>\n<\/td>\n

\n

ZHEJIANG CHANGMING  PHARMACEUTICAL CO., LTD.  CN 317 200 Tiantai<\/span><\/p>\n<\/td>\n

\n

  R0-CEP  2014-162-Rev 00<\/span><\/p>\n<\/td>\n

\n

03\/11\/2016<\/span><\/p>\n<\/td>\n

\n

VALID<\/span><\/p>\n<\/td>\n


<\/td>\n<\/tr>\n
\n

Valsartan<\/span><\/p>\n<\/td>\n

\n

Zhejiang Hisun  Pharmaceutical Co., Ltd. CN  318 000 Taizhou City<\/span><\/p>\n<\/td>\n

\n

  R0-CEP  2013-095-Rev 00<\/span><\/p>\n<\/td>\n

\n

04\/09\/2014<\/span><\/p>\n<\/td>\n

\n

SUSPENDED<\/span><\/p>\n<\/td>\n

\n

28\/10\/2016<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

Valsartan<\/span><\/p>\n<\/td>\n

\n

ZHEJIANG HUAHAI  PHARMACEUTICAL CO., LTD. CN  317 024 Linhai<\/span><\/p>\n<\/td>\n

\n

  R1-CEP  2010-072-Rev 00<\/span><\/p>\n<\/td>\n

\n

09\/06\/2016<\/span><\/p>\n<\/td>\n

\n

SUSPENDED<\/span><\/p>\n<\/td>\n

\n

09\/07\/2018<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

Valsartan<\/span><\/p>\n<\/td>\n

\n

ZHEJIANG TIANYU  PHARMACEUTICAL CO., LTD. CN  318 020 Taizhou<\/span><\/p>\n<\/td>\n

\n

  R0-CEP  2013-159-Rev 01<\/span><\/p>\n<\/td>\n

\n

17\/01\/2018<\/span><\/p>\n<\/td>\n

\n

VALID<\/span><\/p>\n<\/td>\n


<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/span><\/p>\n

\"\u76ee\u524d\u7f2c\u6c99\u5766CEP\u6301\u6709\u60c5\u51b5\"<\/p>\n


<\/p>\n

\n

\u59cb\u53d1\u4e8e\u5fae\u4fe1\u516c\u4f17\u53f7\uff1a \u84b2\u516c\u82f1 <\/p>\n<\/blockquote>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

\u7ffb\u8bd1\uff1aJULIA \u6765\u6e90\uff1aJulia\u6cd5\u89c4\u7ffb\u8bd1  \u76ee\u524d\u7f2c\u6c99\u5766CEP\u6301\u6709\u60c5\u51b5 \u5171\u670928\u4efdCEP\uff0c […]<\/p>\n","protected":false},"author":1,"featured_media":26319,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[2],"tags":[],"_links":{"self":[{"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/posts\/26318"}],"collection":[{"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/comments?post=26318"}],"version-history":[{"count":1,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/posts\/26318\/revisions"}],"predecessor-version":[{"id":26325,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/posts\/26318\/revisions\/26325"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/media\/26319"}],"wp:attachment":[{"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/media?parent=26318"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/categories?post=26318"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/tags?post=26318"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}